Blackstone Inc’s BeOne Medicines Ltd ONC Stock Holding History

Blackstone Inc’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,203	Closed	-$1.58M	–	495
2025 Q4	$1.58M	Buy	+5,203	New	+$1.7M	0.01%	202

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Blackstone Inc's ONC Position: Q1 2026 in Review

Blackstone Inc sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 5,203 shares — an estimated $1.58M sold.

Blackstone Inc first reported a position in ONC in Q4 2025 and held it in 1 quarter. The position peaked at $1.58M in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

Blackstone Inc reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
Blackstone Inc sold 5,203 BeOne Medicines Ltd shares in Q1 2026, an estimated $1.58M.
Blackstone Inc first reported a position in BeOne Medicines Ltd in Q4 2025 and held it in 1 quarter.
Blackstone Inc's BeOne Medicines Ltd position peaked at $1.58M in Q4 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Blackstone Inc's 13F filing for Q1 2026, filed 15 May 2026.